FindTrial
Sign In

Comparative study of effectiveness of two different drugs (ropivacaine and levobupivacaine) in patients undergoing spinal anaesthesia for radiation therapy in gynecological cancers.

Comparative study of effectiveness of intrathecal hyperbaric ropivacaine and hyperbaric levobupivacaine in combination with fentanyl in patients undergoing brachytherapy for gynecological malignancy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075645
Enrollment
50
Registered
2024-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C51-C58- Malignant neoplasms of female genital organs

Interventions

Intervention1: 0/5 % Hyperbaric levobupivacaine: Subarachanoid block using 1.8 ml of 0.5 % hyperbaric levobupivacaine with 25 mcg fentanyl in patients undergoing brachytherapy for gynecological malign

Sponsors

Dr Daphy Andrea Department of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Scheduled for brachytherapy in gynecological malignancy.

Exclusion criteria

Exclusion criteria: Patients with allergy to local anaesthetics patients with severe hepatic, renal and cardiac dysfunction obese patients patients with spinal abnormalities

Design outcomes

Primary

MeasureTime frame
a) Onset of sensory block. b) Onset of motor block. c) Highest level of sensory block d) Side effectsTimepoint: Duration of sensory block(Time period from onset of block to the time of regression to S2) Duration of motor blockade (Time period from onset to Bromage scale 3 to 0.—

Secondary

MeasureTime frame
a) Onset of sensory block. b) Onset of motor block. c) Highest level of sensory block d) Side effectsTimepoint: Time of onset of sensory block (time from intrathecal injection to time to achieve T10 segment level block) Time of onset of motor block (Time from injection of study drug to the time to achieve Bromage scale 3 i.e., patient is unable to move the hip, knee and ankle joint). Time to highest level of sensory blockade. Time for two segment regression of sensory level (time taken for regression of the block to two dermatomal segments after injecting the drug).—

Countries

India

Contacts

Public ContactDAPHY ANDREA A

St.Johns Medical College and Hospital

surbhi_pg@yahoo.com9880109361

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026